Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT04622228 · COMPLETED
Trial details
- NCT number
- NCT04622228
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2022-06-21
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.